CDNA – CareDx Inc

CareDx, Inc. 于1998年12月21日在特拉华州注册成立。公司是一个商业阶段的公司,开发决策市场和给病人提供心脏移植,以帮助临床医生诊断,监控解决方案使治疗个性化。CareDx的第一个商业化的测试方案,AlloMap分子测试心脏移植,或是AlloMap血为基础的测试,用于监测心脏移植术后急性细胞性排斥反应。

中文介绍: https://xueqiu.com/S/CDNA

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey, and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

英文介绍: https://www.morningstar.com/stocks/xnas/cdna/quote

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/cdna-caredx-inc/

发表评论

邮箱地址不会被公开。 必填项已用*标注